Doctor from Brigham and Women's Hospital Discussed Impact of Stratasys 3D Printing in Facial Transplants
MINNEAPOLIS & REHOVOT, Israel--(BUSINESS WIRE)-- Stratasys Ltd. (Nasdaq:SSYS), a global leader of 3D printing and additive manufacturing solutions, announced that Dr. Frank J. Rybicki, the director of Applied Imaging Science Laboratory at Brigham and Women's Hospital, discussed the impact of Stratasys 3D printing for a full-face transplant patient at the 2014 Radiological Society of North America (RSNA) annual meeting in Chicago today.
Dr. Frank J. Rybicki, Brigham and Women’s Hospital, uses 3D printing to visualize soft facial tissue during pre-operative analysis.
Dr. Rybicki and his team visualize 3D printing as an emerging and disruptive technology in medicine today. With the initial application of 3D printing developing skeletal structures, much of the recent research has addressed soft tissue. During the RSNA press conference, Dr. Rybicki discussed the impact of Stratasys 3D printing for soft tissue with transplant patient Carmen Blandin Tarleton. "We've 3D printed the soft tissues before and after Carmen's full-face transplantation. We're going to illustrate those dramatic changes in tissues using a new method that has been previously unavailable," says Dr. Rybicki. "The soft tissues that are 3D printed in one piece are much better than photographs. They provide a better understanding of what's between the skin and bones than any two-dimensional representation can." To learn more, watch this CBS Chicago segment that offers more insight into how 3D printers can help doctors change lives.
During the RSNA press conference, Dr. Rybicki illustrated the potential of Stratasys 3D models form pre- and post-op situations. Printed from the Stratasys Objet500 Connex3 and the Objet Eden 260VS, models showed simulated facial tissue and bone structure, as well as how Dr. Rybicki's team is using them to better understand the state of soft tissue at various stages in time.
"The medical research and advancements brought on by 3D printing is truly life altering. We strive to empower the healthcare heroes with technologies, materials and work flow to help advance their cause," says Gilad Gans, President, Stratasys North America. "Dr. Rybicki and his team are changing lives and using Stratasys' most advanced 3D printing technology."
For more information on the Brigham and Women's Applied Imaging Science Laboratory, visit their website.
For more information on the 2014 Radiological Society of North America annual meeting, visit their website.
Stratasys Ltd. (Nasdaq:SSYS), headquartered in Minneapolis, Minnesota and Rehovot, Israel, is a leading global provider of 3D printing and additive manufacturing solutions. The company's patented FDM®, PolyJet™, and WDM™ 3D Printing technologies produce prototypes and manufactured goods directly from 3D CAD files or other 3D content. Systems include 3D printers for idea development, prototyping and direct digital manufacturing. Stratasys subsidiaries include MakerBot and Solidscape, and the company operates a digital-manufacturing service, comprising RedEye, Harvest Technologies and Solid Concepts. Stratasys has more than 2,800 employees, holds over 600 granted or pending additive manufacturing patents globally, and has received more than 25 awards for its technology and leadership. Online at: www.stratasys.com or http://blog.stratasys.com.
Stratasys and Objet are registered trademarks, and PolyJet is a trademark of Stratasys Ltd. and or its subsidiaries or affiliates.
Attention Editors, if you publish reader-contact information, please use:
Europe/Middle East/Africa +49-7229-7772-0
Asia Pacific +852 39448888
Stratasys Media Contacts
Jonathan Wake / Miguel Afonso
Arita Mattsoff / Joe Hiemenz
Tel. +972-(0)74-745-4000 (IL)
Tel. +1-952-906-2726 (US)
Tel. +852 3944 8890
Tel. +81 90 6473 1812
Tel. +852 3944 8890
Tel. +52 1 (55) 4866-0800
Source: Stratasys Ltd.
News Provided by Acquire Media
Close window | Back to top